Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of OXytocin in Acute Ischemic Stroke reconvAlesceNcE: The ROXANE Study

NCT05873309 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT05873309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05873309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of OXytocin in Acute Ischemic Stroke reconvAlesceNcE: The ROXANE Study
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Completed
Start date
April 26, 2023
Completion date
December 31, 2024
Enrollment
386 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke